Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Task-shifting to nonexperts using artificial intelligence-guided point-of-care ultrasound: a cohort study of patient selection, image quality, and learning curves.

European heart journal. Imaging methods and practiceยท2026
Same author

Regional fat distribution as a determinant of mortality in populations with left ventricular systolic dysfunction: challenging the obesity paradox.

European journal of preventive cardiologyยท2026
Same author

The bilirubin-to-albumin ratio as a potential prognostic biomarker for all-cause mortality in patients with acute decompensated cirrhosis: A prospective study.

PloS oneยท2025
Same author

Lipoprotein(a) in Vietnamese Cardiologists: Findings From a Pilot Study at the Vietnam Atherosclerosis Society Congress.

Health science reportsยท2025
Same author

Clarifying the cognitive mechanisms and isolated effects of plaque visualization in cardiovascular risk reduction: reply.

European journal of preventive cardiologyยท2025
Same author

Association of Cognitive Impairment With Evolution of Heart Failure.

Journal of the American Heart Associationยท2025

Related Experiment Videos

Diagnostic Tests for Stage B Heart Failure.

Hai Nguyen Ngoc Dang1,2, Thang Viet Luong1, Quan Huynh1,3

  • 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Current Cardiology Reports
|July 3, 2026
PubMed
Summary

Diagnosing Stage B heart failure (SBHF) is improving with new technologies. Advanced imaging, biomarkers, and artificial intelligence (AI) aid in early detection and risk stratification, potentially preventing symptomatic heart failure.

Keywords:
Artificial intelligenceCardiac biomarkersEchocardiographyStage B heart failureSubclinical heart failure

Related Experiment Videos

Area of Science:

  • Cardiology
  • Diagnostic Medicine
  • Biomarkers

Background:

  • Stage B heart failure (SBHF) is a subclinical phase of heart failure characterized by structural cardiac abnormalities, functional impairment, or abnormal cardiac biomarkers.
  • Historically, recognizing SBHF in the community has been challenging due to its asymptomatic nature.
  • Early detection and intervention in SBHF are crucial to prevent progression to symptomatic heart failure and reduce the associated clinical and economic burden.

Purpose of the Study:

  • To provide a comprehensive overview of current diagnostic tests for Stage B heart failure (SBHF).
  • To synthesize evidence from clinical guidelines and studies on SBHF diagnostics.
  • To explore the role of emerging technologies in SBHF detection.

Main Methods:

  • Review of diagnostic guidelines and clinical studies for Stage B heart failure.
  • Highlighting the utility of transthoracic echocardiography, including speckle tracking echocardiography.
  • Evaluating the role of circulating biomarkers such as natriuretic peptides and high-sensitivity cardiac troponins.
  • Assessing adjunctive diagnostic approaches including ECG, chest X-ray, cardiac MRI, CT, nuclear imaging, and exercise stress testing.
  • Exploring emerging applications of artificial intelligence (AI) in SBHF diagnosis.

Main Results:

  • Transthoracic echocardiography is a cornerstone for detecting subclinical myocardial remodeling and dysfunction in SBHF.
  • Circulating biomarkers (natriuretic peptides, troponins) are valuable for SBHF detection and risk stratification.
  • Various imaging modalities and tests (ECG, MRI, CT, etc.) play adjunctive roles in specific clinical scenarios.
  • Artificial intelligence shows promise for enhancing diagnostic precision, scalability, and early detection of SBHF.
  • Advances in diagnostics offer a critical window for intervention in SBHF to prevent progression.

Conclusions:

  • Modern diagnostic tools, including advanced imaging and biomarkers, significantly improve the ability to identify Stage B heart failure.
  • Artificial intelligence presents a promising avenue for more precise and scalable early detection of SBHF.
  • Timely identification and intervention during the SBHF stage can potentially mitigate progression to symptomatic heart failure and reduce long-term healthcare costs.